Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling

G. Paonessa, R. Graziani, A. De Serio, R. Savino, L. Ciapponi, A. Lahm, A. L. Salvati, C. Toniatti, G. Ciliberto

Research output: Contribution to journalArticle

193 Citations (Scopus)

Abstract

Tile helical cytokine interleukin (IL) 6 and its specific binding subunit IL-6Rcα form a 1:1 complex which, by promoting homodimerization of the signalling subunit gp130 on the surface of target cells, triggers intracellular responses. We expressed differently tagged forms of gp130 and used them in solution-phase binding assays to show that the soluble extracellular domains of gp130 undergo dimerization in the absence of membranes. In vitro receptor assembly reactions were also performed in the presence of two sets of IL-6 variants carrying amino acid substitutions in two distinct areas of the cytokine surface (site 2, comprising exposed residues in the A and C helices, and site 3, in the terminal part of the CD loop). The binding affinity to IL-6Rα of these variants is normal but their biological activity is poor or absent. We demonstrate here that both the site 2 and site 3 IL-6 variants complexed with IL-6Rα bind a single gp130 molecule but are unable to dimerize it, whereas the combined site 2/3 variants lose the ability to interact with gp130. The binding properties of these variants in vitro, and the result of using a neutralizing monoclonal antibody directed against site 3, lead to the conclusion that gp130 dimer is formed through direct binding at two independent and differently oriented sites on IL-6. Immunoprecipitation experiments further reveal that the fully assembled receptor complex is composed of two IL-6, two IL-6Rα and two gp130 molecules. We propose here a model representing the IL-6 receptor complex as hexameric, which might be common to other helical cytokines.

Original languageEnglish
Pages (from-to)1942-1951
Number of pages10
JournalEMBO Journal
Volume14
Issue number9
Publication statusPublished - 1995

Fingerprint

Dimers
Interleukins
Interleukin-6
Cytokines
Interleukin-6 Receptors
Molecules
Dimerization
Amino Acid Substitution
Tile
Bioactivity
Neutralizing Antibodies
Immunoprecipitation
Assays
Substitution reactions
Monoclonal Antibodies
Membranes
Amino Acids
Experiments
In Vitro Techniques

Keywords

  • gp130 dimer
  • IL-6 receptor antagonist
  • IL-6 receptor complex
  • IL-6Rα

ASJC Scopus subject areas

  • Cell Biology
  • Genetics

Cite this

Paonessa, G., Graziani, R., De Serio, A., Savino, R., Ciapponi, L., Lahm, A., ... Ciliberto, G. (1995). Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling. EMBO Journal, 14(9), 1942-1951.

Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling. / Paonessa, G.; Graziani, R.; De Serio, A.; Savino, R.; Ciapponi, L.; Lahm, A.; Salvati, A. L.; Toniatti, C.; Ciliberto, G.

In: EMBO Journal, Vol. 14, No. 9, 1995, p. 1942-1951.

Research output: Contribution to journalArticle

Paonessa, G, Graziani, R, De Serio, A, Savino, R, Ciapponi, L, Lahm, A, Salvati, AL, Toniatti, C & Ciliberto, G 1995, 'Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling', EMBO Journal, vol. 14, no. 9, pp. 1942-1951.
Paonessa G, Graziani R, De Serio A, Savino R, Ciapponi L, Lahm A et al. Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling. EMBO Journal. 1995;14(9):1942-1951.
Paonessa, G. ; Graziani, R. ; De Serio, A. ; Savino, R. ; Ciapponi, L. ; Lahm, A. ; Salvati, A. L. ; Toniatti, C. ; Ciliberto, G. / Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling. In: EMBO Journal. 1995 ; Vol. 14, No. 9. pp. 1942-1951.
@article{03c63ed8449b4e52826c9e3d51067d71,
title = "Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling",
abstract = "Tile helical cytokine interleukin (IL) 6 and its specific binding subunit IL-6Rcα form a 1:1 complex which, by promoting homodimerization of the signalling subunit gp130 on the surface of target cells, triggers intracellular responses. We expressed differently tagged forms of gp130 and used them in solution-phase binding assays to show that the soluble extracellular domains of gp130 undergo dimerization in the absence of membranes. In vitro receptor assembly reactions were also performed in the presence of two sets of IL-6 variants carrying amino acid substitutions in two distinct areas of the cytokine surface (site 2, comprising exposed residues in the A and C helices, and site 3, in the terminal part of the CD loop). The binding affinity to IL-6Rα of these variants is normal but their biological activity is poor or absent. We demonstrate here that both the site 2 and site 3 IL-6 variants complexed with IL-6Rα bind a single gp130 molecule but are unable to dimerize it, whereas the combined site 2/3 variants lose the ability to interact with gp130. The binding properties of these variants in vitro, and the result of using a neutralizing monoclonal antibody directed against site 3, lead to the conclusion that gp130 dimer is formed through direct binding at two independent and differently oriented sites on IL-6. Immunoprecipitation experiments further reveal that the fully assembled receptor complex is composed of two IL-6, two IL-6Rα and two gp130 molecules. We propose here a model representing the IL-6 receptor complex as hexameric, which might be common to other helical cytokines.",
keywords = "gp130 dimer, IL-6 receptor antagonist, IL-6 receptor complex, IL-6Rα",
author = "G. Paonessa and R. Graziani and {De Serio}, A. and R. Savino and L. Ciapponi and A. Lahm and Salvati, {A. L.} and C. Toniatti and G. Ciliberto",
year = "1995",
language = "English",
volume = "14",
pages = "1942--1951",
journal = "EMBO Journal",
issn = "0261-4189",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling

AU - Paonessa, G.

AU - Graziani, R.

AU - De Serio, A.

AU - Savino, R.

AU - Ciapponi, L.

AU - Lahm, A.

AU - Salvati, A. L.

AU - Toniatti, C.

AU - Ciliberto, G.

PY - 1995

Y1 - 1995

N2 - Tile helical cytokine interleukin (IL) 6 and its specific binding subunit IL-6Rcα form a 1:1 complex which, by promoting homodimerization of the signalling subunit gp130 on the surface of target cells, triggers intracellular responses. We expressed differently tagged forms of gp130 and used them in solution-phase binding assays to show that the soluble extracellular domains of gp130 undergo dimerization in the absence of membranes. In vitro receptor assembly reactions were also performed in the presence of two sets of IL-6 variants carrying amino acid substitutions in two distinct areas of the cytokine surface (site 2, comprising exposed residues in the A and C helices, and site 3, in the terminal part of the CD loop). The binding affinity to IL-6Rα of these variants is normal but their biological activity is poor or absent. We demonstrate here that both the site 2 and site 3 IL-6 variants complexed with IL-6Rα bind a single gp130 molecule but are unable to dimerize it, whereas the combined site 2/3 variants lose the ability to interact with gp130. The binding properties of these variants in vitro, and the result of using a neutralizing monoclonal antibody directed against site 3, lead to the conclusion that gp130 dimer is formed through direct binding at two independent and differently oriented sites on IL-6. Immunoprecipitation experiments further reveal that the fully assembled receptor complex is composed of two IL-6, two IL-6Rα and two gp130 molecules. We propose here a model representing the IL-6 receptor complex as hexameric, which might be common to other helical cytokines.

AB - Tile helical cytokine interleukin (IL) 6 and its specific binding subunit IL-6Rcα form a 1:1 complex which, by promoting homodimerization of the signalling subunit gp130 on the surface of target cells, triggers intracellular responses. We expressed differently tagged forms of gp130 and used them in solution-phase binding assays to show that the soluble extracellular domains of gp130 undergo dimerization in the absence of membranes. In vitro receptor assembly reactions were also performed in the presence of two sets of IL-6 variants carrying amino acid substitutions in two distinct areas of the cytokine surface (site 2, comprising exposed residues in the A and C helices, and site 3, in the terminal part of the CD loop). The binding affinity to IL-6Rα of these variants is normal but their biological activity is poor or absent. We demonstrate here that both the site 2 and site 3 IL-6 variants complexed with IL-6Rα bind a single gp130 molecule but are unable to dimerize it, whereas the combined site 2/3 variants lose the ability to interact with gp130. The binding properties of these variants in vitro, and the result of using a neutralizing monoclonal antibody directed against site 3, lead to the conclusion that gp130 dimer is formed through direct binding at two independent and differently oriented sites on IL-6. Immunoprecipitation experiments further reveal that the fully assembled receptor complex is composed of two IL-6, two IL-6Rα and two gp130 molecules. We propose here a model representing the IL-6 receptor complex as hexameric, which might be common to other helical cytokines.

KW - gp130 dimer

KW - IL-6 receptor antagonist

KW - IL-6 receptor complex

KW - IL-6Rα

UR - http://www.scopus.com/inward/record.url?scp=0029002866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029002866&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 1942

EP - 1951

JO - EMBO Journal

JF - EMBO Journal

SN - 0261-4189

IS - 9

ER -